Revolution Medicines' Pancreatic Cancer Pill Doubles Survival, Cuts Death Risk 60% in Trial As Stock Sits
Stock Market Hits Highs On Iran Hopes; Goldman Sachs, Netflix, Taiwan Semiconductor In Focus: Weekly Review